Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
02/09/2006 | WO2006014405A2 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
02/09/2006 | WO2006014024A1 Therapeutic agent for psychoneurotic disease |
02/09/2006 | WO2006014012A2 Aromatic compounds |
02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
02/09/2006 | US20060030714 Reacting a 2,5-dihalopyridine with an alkyllithium and a enolizable aldehyde or ketone to form a 2-(optionally disubstituted hydroxymethyl)-5-halopyridine while quenching with a proton donor |
02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
02/09/2006 | US20060030712 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
02/09/2006 | US20060030603 Novel aryl urea analogs and use thereof as antibacterial agents |
02/09/2006 | US20060030601 Novel aminopyridine derivatives as mGluR5 antagonists |
02/09/2006 | US20060030599 Sulphonamide derivatives |
02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
02/09/2006 | US20060030553 Cell adhesion inhibitors |
02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
02/09/2006 | CA2575894A1 Dual nk1/nk3 antagonists against schizophrenia |
02/09/2006 | CA2574956A1 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
02/09/2006 | CA2573223A1 Aromatic compound |
02/08/2006 | EP1623977A1 Intermediate compound which is used for the preparation of pioglitazone |
02/08/2006 | EP1623973A1 Platinum complex |
02/08/2006 | EP1622898A1 Processes for making thiazolidinedione derivatives and compounds thereof |
02/08/2006 | EP1622891A1 Stable ammonium salts of alpha-liponic acid, the production there of and the use of the same |
02/08/2006 | EP1622869A1 Glyoxalase inhibitors |
02/08/2006 | EP1622867A1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
02/08/2006 | EP1404696B1 Activators for oligonucleotide synthesis |
02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
02/08/2006 | EP1183243B1 Short-acting benzodiazepines |
02/08/2006 | EP1144348B1 Lta 4 hydrolase inhibitors |
02/08/2006 | EP1131292B1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
02/08/2006 | CN1732175A Method for producing pyridoxine or an acid addition salt thereof |
02/08/2006 | CN1732166A Novel herbicides |
02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
02/08/2006 | CN1732152A Phenethanolamine derivative for the treatment of respiratory diseases |
02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
02/08/2006 | CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
02/08/2006 | CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
02/08/2006 | CN1730481A 5-aza-indole preparation method |
02/08/2006 | CN1240683C Method for preparing 2-aminopyridine and alkyl derivative |
02/08/2006 | CN1240682C Novel bactericide of 4-[3-(pyridine-4-yl)-3-substituted phenyl acryloyl] morpholine |
02/08/2006 | CN1240677C Monofluoroalkyl derivatives |
02/07/2006 | US6995269 Guanidinobenzamides |
02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
02/07/2006 | US6995178 Insecticidal anthranilamides |
02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
02/07/2006 | US6995110 Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst |
02/07/2006 | US6994283 Method for pulverizing to fine powder |
02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
02/02/2006 | WO2006012320A1 Process for the preparation of 4-trifluoromethyl-2(1h)-pyridinone |
02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
02/02/2006 | WO2006011050A2 Pyridine derivatives |
02/02/2006 | WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
02/02/2006 | WO2006010637A2 Pyridinylamines |
02/02/2006 | WO2006010546A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
02/02/2006 | WO2005118541A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/02/2006 | WO2005103032A3 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
02/02/2006 | WO2005103002A3 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds |
02/02/2006 | WO2005084368A3 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues |
02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
02/02/2006 | US20060025594 Small molecule entry inhibitors |
02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
02/02/2006 | US20060025456 Serotonin reuptake inhibitors; dimethyl-(2-pyridin-3-yl-cyclohex-1-enylmethyl)-amine and the corresponding dihydrochloride; analgesics, anxiety disorders; side effects reduction |
02/02/2006 | US20060025455 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
02/02/2006 | DE102004033525A1 Verbessertes Verfahren zur Herstellung kernfluorierter Aromaten Improved process for preparing aromatic kernfluorierter |
02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
02/02/2006 | CA2575283A1 Method for the preparation of crystal forms of torsemide in a pure state |
02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
02/02/2006 | CA2573409A1 Preparation of novel substituted haloarene compounds |
02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
02/01/2006 | EP1620404A1 Novel process for the preparation of 2-aminomethylpyridine derivatives |
02/01/2006 | EP1620397A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
02/01/2006 | EP1453808B1 Pyridine-3-sulfonyl compounds as pesticidal agents |
02/01/2006 | EP1444205B1 Method for producing 2-halogen-pyridine-carboxylic acid amides |
02/01/2006 | EP0970057B1 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
02/01/2006 | EP0859613B1 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |